Boomerang Therapeutics · raw details

Personalized Cancer Gene Therapy · Be'er Sheva · Founded 2015

inactive Pre-Funding ← back to profile

Highlights

1 patentProfile claimed by owner

About

Personalized Cancer Gene Therapy

Boomerang Therapeutics develops a genetic device for cancer therapy. Using advanced gene editing tools, thesystem is able to effectively eliminate cancer cells by activating suicide genes. Thesystem can be potentially designed according to the genetics of each patient's tumor, paving the way to personalized treatment.

Identity

NameBoomerang Therapeutics
Slugboomerang-therapeutics
Type / kindstartup
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKW9y4YIDA

Status

Statusinactive
Status reasonNon Active, Jan 2017
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtSouth District
HQ cityBe'er Sheva
HQ addressBe'er Sheva, Israel

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
genetic-engineeringmolecular-biologygenomicspersonalized-medicine

Funding

Total raised—
Current stagePre-Funding

Raw source document

Show full JSON (0 KB) 
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}